These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 12619101)

  • 1. Sarcomatous cholangiocarcinoma.
    Gupta K; Powari M; Dey P
    Diagn Cytopathol; 2003 Mar; 28(3):168-9. PubMed ID: 12619101
    [No Abstract]   [Full Text] [Related]  

  • 2. Pathology of combined hepatocellular-cholangiocarcinoma.
    Yeh MM
    J Gastroenterol Hepatol; 2010 Sep; 25(9):1485-92. PubMed ID: 20796144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The utility of keratin 903 as a new prognostic marker in mass-forming-type intrahepatic cholangiocarcinoma.
    Aishima S; Asayama Y; Taguchi K; Sugimachi K; Shirabe K; Shimada M; Sugimachi K; Tsuneyoshi M
    Mod Pathol; 2002 Nov; 15(11):1181-90. PubMed ID: 12429797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A subgroup of intrahepatic cholangiocarcinoma with an infiltrating replacement growth pattern and a resemblance to reactive proliferating bile ductules: 'bile ductular carcinoma'.
    Kozaka K; Sasaki M; Fujii T; Harada K; Zen Y; Sato Y; Sawada S; Minato H; Matsui O; Nakanuma Y
    Histopathology; 2007 Sep; 51(3):390-400. PubMed ID: 17553067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A combined hepatocellular/cholangiocellular carcinoma with sarcomatoid features.
    Papotti M; Sambataro D; Marchesa P; Negro F
    Liver; 1997 Feb; 17(1):47-52. PubMed ID: 9062880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of sarcomatous cholangiocarcinoma of the liver.
    Shimada M; Takenaka K; Rikimaru T; Hamatsu T; Yamashita Y; Kajiyama K; Taguchi K; Shirabe K; Sugimachi K
    Hepatogastroenterology; 2000; 47(34):956-61. PubMed ID: 11020857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular and stromal characteristics in the scirrhous hepatocellular carcinoma: comparison with hepatocellular carcinomas and intrahepatic cholangiocarcinomas.
    Okamura N; Yoshida M; Shibuya A; Sugiura H; Okayasu I; Ohbu M
    Pathol Int; 2005 Nov; 55(11):724-31. PubMed ID: 16271085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of immunohistochemical markers for differential diagnosis of hepatocellular carcinoma from intrahepatic cholangiocarcinoma].
    Dong H; Cong WL; Zhu ZZ; Wang B; Xian ZH; Yu H
    Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):702-5. PubMed ID: 19173916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pathology of cholangiocarcinoma].
    Guedj N; Bedossa P; Paradis V
    Ann Pathol; 2010 Dec; 30(6):455-63. PubMed ID: 21167432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Three deceptive cases of intrahepatic metastases of colorectal origin with endobiliary growth, simulating cholangiocarcinoma. Importance of immunostaining of cytokeratin 7 and 20].
    Rullier A; Le Bail B; Rullier E; Lamouliatte H; Saric J; Bioulac-Sage P
    Ann Pathol; 1999 Mar; 19(1):33-6. PubMed ID: 10320910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary liver cancer with dual expression of hepatocyte and bile duct epithelial markers.
    Uenishi T; Hirohashi K; Shuto T; Tsukamoto T; Yamamoto T; Ogawa M; Kubo S; Tanaka H; Kinoshita H
    Hepatogastroenterology; 2002; 49(46):1092-4. PubMed ID: 12143210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary liver carcinoma in genetic hemochromatosis reveals a broad histologic spectrum.
    Morcos M; Dubois S; Bralet MP; Belghiti J; Degott C; Terris B
    Am J Clin Pathol; 2001 Nov; 116(5):738-43. PubMed ID: 11710692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphoepithelioma-like cholangiocarcinoma (LELC) not associated with Epstein-Barr virus.
    Szekely E
    Am J Surg Pathol; 2001 Nov; 25(11):1464-6. PubMed ID: 11684969
    [No Abstract]   [Full Text] [Related]  

  • 14. Intraperitoneal rupture of cholangiocarcinoma in a patient with liver cirrhosis, type C, with hepatocellular carcinoma.
    Watanabe M; Akagi S; Hamamoto S
    Am J Gastroenterol; 1999 Aug; 94(8):2320-1. PubMed ID: 10445582
    [No Abstract]   [Full Text] [Related]  

  • 15. Case report combined hepatocellular and cholangiocarcinoma with sarcomatous transformation.
    Boonsakan P; Thangnapakorn O; Tapaneeyakorn J; Kositchaiwat S; Bunyaratvej S
    J Med Assoc Thai; 2007 Mar; 90(3):574-80. PubMed ID: 17427538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mixed hepatocellular-cholangiocarcinoma may derive from "hepatogones".
    Hunt JP; Varnholt H
    Hepatobiliary Pancreat Dis Int; 2008 Feb; 7(1):105; author reply 105-6. PubMed ID: 18234649
    [No Abstract]   [Full Text] [Related]  

  • 17. Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis.
    Boberg KM; Jebsen P; Clausen OP; Foss A; Aabakken L; Schrumpf E
    J Hepatol; 2006 Oct; 45(4):568-74. PubMed ID: 16879890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrahepatic sarcomatoid cholangiocarcinoma: clinical analysis of seven cases during a 15-year period.
    Tsou YK; Wu RC; Hung CF; Lee CS
    Chang Gung Med J; 2008; 31(6):599-605. PubMed ID: 19241900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholangiolocellular carcinoma: an innocent-looking malignant liver tumor mimicking ductular reaction.
    Sempoux C; Fan C; Singh P; Obeidat K; Roayaie S; Schwartz M; Fiel MI; Thung SN
    Semin Liver Dis; 2011 Feb; 31(1):104-10. PubMed ID: 21344355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunostaining for polycomb group protein EZH2 and senescent marker p16INK4a may be useful to differentiate cholangiolocellular carcinoma from ductular reaction and bile duct adenoma.
    Sasaki M; Matsubara T; Kakuda Y; Sato Y; Nakanuma Y
    Am J Surg Pathol; 2014 Mar; 38(3):364-9. PubMed ID: 24487593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.